Literature DB >> 15121169

Polyethylenimine strategies for plasmid delivery to brain-derived cells.

Chun Zhang1, Preeti Yadava, Jeffrey Hughes.   

Abstract

The introduction of effective transfection reagents has had a dramatic impact on basic scientific studies over the past decade and is methodically becoming a clinical relevant agent. An area where these agents have had little impact to date is in transfection of neuronal cells either in vivo or in vitro. The poor results, obtained with these cells, likely arise from the innate properties of the cell itself such as its post-mitotic state and its fragility to the transfection agent. In this report, we investigated the transfection efficiency of branched and linear form of polyethylenimine (PEI) for a commonly used tissue culture cell line, the human CF bronchial epithelial cell line IB3-1, rat brain-derived glial, and neuronal cell lines. In addition, the effect of reaction conditions, such as ratio of PEI/plasmid, polymer molecular weight, and shape, was addressed on the transfection effects. The results indicate that branched PEI is more effective for the brain-derived cells. It is also shown that PEI 25 is more effective for the glial cells and PEI 50-100 is more effective for the neuronal cells under the evaluation conditions. Copyright 2003 Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15121169     DOI: 10.1016/j.ymeth.2003.11.004

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  12 in total

1.  Diseases originate and terminate by genes: unraveling nonviral gene delivery.

Authors:  Rajan Swami; Indu Singh; Wahid Khan; Sistla Ramakrishna
Journal:  Drug Deliv Transl Res       Date:  2013-12       Impact factor: 4.617

Review 2.  Non-viral gene therapy for spinal cord regeneration.

Authors:  Li Yao; Sheng Yao; William Daly; William Hendry; Anthony Windebank; Abhay Pandit
Journal:  Drug Discov Today       Date:  2012-05-24       Impact factor: 7.851

Review 3.  Gene-Modified Stem Cells for Spinal Cord Injury: a Promising Better Alternative Therapy.

Authors:  Yirui Feng; Yu Li; Ping-Ping Shen; Bin Wang
Journal:  Stem Cell Rev Rep       Date:  2022-05-19       Impact factor: 5.739

4.  De novo induction of genetically engineered brain tumors in mice using plasmid DNA.

Authors:  Stephen M Wiesner; Stacy A Decker; Jon D Larson; Katya Ericson; Colleen Forster; Jose L Gallardo; Chunmei Long; Zachary L Demorest; Edward A Zamora; Walter C Low; Karen SantaCruz; David A Largaespada; John R Ohlfest
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

5.  New polymer of lactic-co-glycolic acid-modified polyethylenimine for nucleic acid delivery.

Authors:  Jian-Ming Lü; Zhengdong Liang; Xiaoxiao Wang; Jianhua Gu; Qizhi Yao; Changyi Chen
Journal:  Nanomedicine (Lond)       Date:  2016-07-26       Impact factor: 5.307

6.  Vinculin tension distributions of individual stress fibers within cell-matrix adhesions.

Authors:  Ching-Wei Chang; Sanjay Kumar
Journal:  J Cell Sci       Date:  2013-05-17       Impact factor: 5.285

7.  Bifunctional chimeric fusion proteins engineered for DNA delivery: optimization of the protein to DNA ratio.

Authors:  Shan Gao; Melissa J Simon; Barclay Morrison; Scott Banta
Journal:  Biochim Biophys Acta       Date:  2009-03

Review 8.  Barriers to non-viral vector-mediated gene delivery in the nervous system.

Authors:  Francisco C Pérez-Martínez; Javier Guerra; Inmaculada Posadas; Valentín Ceña
Journal:  Pharm Res       Date:  2011-01-12       Impact factor: 4.200

9.  Gene delivery ability of polyethylenimine and polyethylene glycol dual-functionalized nanographene oxide in 11 different cell lines.

Authors:  Liping Wu; Jinshan Xie; Tan Li; Zihao Mai; Lu Wang; Xiaoping Wang; Tongsheng Chen
Journal:  R Soc Open Sci       Date:  2017-10-25       Impact factor: 2.963

10.  Voltage Preconditioning Allows Modulated Gene Expression in Neurons Using PEI-complexed siRNA.

Authors:  Arati Sridharan; Chetan Patel; Jit Muthuswamy
Journal:  Mol Ther Nucleic Acids       Date:  2013-03-26       Impact factor: 10.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.